# Baxter International Inc. (NYSE:BAX)

> Baxter is committed to high standards of corporate governance, which is essential for maintaining investor and public confidence.

## About

Baxter is committed to high standards of corporate governance, which is essential for maintaining investor and public confidence. The company emphasizes strong governance through its Board of Directors, ethical conduct, and comprehensive policies that guide its operations and interactions with stakeholders.

## Key facts

- **Leadership:** William A. Ampofo II (Senior Vice President, Parts & Distribution and Supply Chain, Boeing Global Services), Jeffrey (Jay) A. Craig (Former Chair and Chief Executive Officer, Meritor Corporation), Andrew Hider (President and Chief Executive Officer), Michael R. McDonnell (Former Executive Vice President and Chief Financial Officer, Biogen Inc.), Patricia B. Morrison (Former Executive Vice President, Customer Support Services and Chief Information Officer, Cardinal Health Inc.), Nancy M. Schlichting (Former President and Chief Executive Officer, Henry Ford Health System), Brent Shafer (Chair of the Board and Former Chair and Chief Executive Officer, Cerner Corporation), Amy A. Wendell (Former Senior Vice President, Strategy and Business Development and Licensing, Covidien), David S. Wilkes, M.D. (Dean Emeritus of the University of Virginia School of Medicine), James Borzi (Executive Vice President, Chief Supply Chain Officer), Cynthia (Cindy) Carlisle (Executive Vice President and Chief Human Resources Officer), Stacey Eisen (Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation), Julie Foster (President, Front Line Care), Adriana Guiry (Senior Vice President, Baxter Growth & Performance System), Scott Kaplan (Senior Vice President, Quality, Regulatory & Patient Safety), Piero Novello (Senior Vice President and President, International), Charles (Rusty) Patel (Senior Vice President and Chief Information Officer), David S. Rosenbloom (Executive Vice President and General Counsel), Cecilia Soriano (Group President, Infusion Therapies and Platforms), James Teaff (President, Care & Connectivity Solutions), Steve Wallace (President, Advanced Surgery & Commercial Excellence), Anita Zielinski (Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller)

_Verified data last updated: 2026-08-07_

## Recent filings

- 2026-08-04 — other — [bax_2026-08-04_20-22-22.pdf](https://chat.orbiton.app/bax/preview/110684?documentId=110684)
- 2026-08-04 — other — [bax_2026-08-04_11-32-33.pdf](https://chat.orbiton.app/bax/preview/110685?documentId=110685)
- 2026-07-30 — financials — [bax_2026-07-30_19-45-57.pdf](https://chat.orbiton.app/bax/preview/110686?documentId=110686)
- 2026-07-30 — other — [bax_2026-07-30_10-17-40.pdf](https://chat.orbiton.app/bax/preview/110687?documentId=110687)
- 2026-07-14 — other — [bax_2026-07-14_19-15-49.pdf](https://chat.orbiton.app/bax/preview/110688?documentId=110688)
- 2026-06-05 — other — [bax_2026-06-05_13-13-06.pdf](https://chat.orbiton.app/bax/preview/110689?documentId=110689)
- 2026-06-03 — other — [bax_2026-06-03_19-07-23.pdf](https://chat.orbiton.app/bax/preview/110690?documentId=110690)
- 2026-06-03 — other — [bax_2026-06-03_19-06-38.pdf](https://chat.orbiton.app/bax/preview/110691?documentId=110691)

## Live AI chat

- https://chat.orbiton.app/bax/chat
- Investor website: https://baxter.com/